CoreTissue BioEngineering

CoreTissue BioEngineering

We are experts in developing medical devices from decellularized animal tissue.

Launch date
Employees
Market cap
-
Enterprise valuation
AUD27—40m (Dealroom.co estimates Feb 2023.)
Tokyo Japan (HQ)
  • Edit
DateInvestorsAmountRound
-

N/A

-
N/A

N/A

Seed
N/A

N/A

Seed
N/A

N/A

-

N/A

Early VC
N/A

JPY560m

Series A
Total FundingAUD6.7m

Recent News about CoreTissue BioEngineering

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.